| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071293 Protein; biological antigrowth agent; bactericides |
| 07/04/2006 | US7071232 Small molecules that increase the conversion of food to body weight gain |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071168 To inhibit tumor growth in an animal; to induce apoptosis |
| 06/29/2006 | WO2006067091A1 Myd88 homodimerization inhibitors |
| 06/29/2006 | WO2005118620A3 Methods for preparing internally constraied peptides and peptidomimetics |
| 06/29/2006 | WO2004019880A3 Aw755252-interacting proteins and use thereof |
| 06/29/2006 | US20060142305 N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazinium hydrogen sulfate; N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyguanidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide; urokinase plasminogen activator inhibitor; anticarcinogenic agent |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142204 Pyrrolidine derivatives for use in treating heaptitis c virus infection |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | CA2591785A1 Antibody binding affinity ligands |
| 06/29/2006 | CA2590750A1 Myd88 homodimerization inhibitors |
| 06/28/2006 | EP1674580A1 Method for identifying activators and/or inhibitors of enzyme activity |
| 06/28/2006 | EP1674477A2 Binding polypeptides for B lymphocyte stimulator protein (BLYS) |
| 06/28/2006 | EP1673633A1 Method and device for detecting feline immunodeficiency virus |
| 06/28/2006 | EP1673385A1 Macrocyclic peptides active against the hepatitis c virus |
| 06/28/2006 | EP1673384A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/28/2006 | EP1358205B1 Tetrapeptidic tryptase substrates and assay for tryptase activity using same |
| 06/28/2006 | EP1254159B9 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 06/28/2006 | EP1142905B1 Novel depsipeptide compound |
| 06/28/2006 | EP0693129B1 Method of inhibiting the transcription of genes |
| 06/28/2006 | CN1795183A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 06/28/2006 | CN1261449C Melanocyte-stimulating hormone inhibitors |
| 06/27/2006 | US7067698 Preparation of preferential oligomers for use as therapeutic tools; obtain oligomer, incubate with amines, expose to guanidinylation reagent, recover oligomer |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067491 3,3,3-trifluoro-1-(methylethyl)-2-oxopropyl]carbamoyl}pyrrolidinyl) derivatives; useful for prophylaxis and treatment for various diseases caused by increased elastase activity, such as diseases caused by increased protein degradation by elastase, especially respiratory diseases |
| 06/27/2006 | US7067476 Peptide derivative containing hydroxy or carbonyl groups and a residue of arganine and lysine side chain in which guanidino and amino groups are protected; used for periodontal disease |
| 06/27/2006 | US7067326 Binding particle for use in the biosynthesis and separation of particles in sample |
| 06/27/2006 | US7067257 For treatment of encephalomyelitis, leukodystrophy, adrenoleukodystrophy, migraines, epilepsy, Alzheimer's/Parkinson's diseases, and neuron diseases |
| 06/22/2006 | WO2006063706A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 06/22/2006 | WO2006024741A3 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 06/22/2006 | WO2006019632A3 Cell adhesion inhibitors |
| 06/22/2006 | WO2005105832A3 Biologically active peptide vapeehptllteaplnpk derivatives |
| 06/22/2006 | WO2005087731A8 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/22/2006 | US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/22/2006 | US20060135438 Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux |
| 06/22/2006 | US20060135436 Peptides and methods for the control of obesity |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135428 kringle peptides; peptidase stabilized |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060135409 Process for and intermediates in the preparation of canfosfamide and its salts |
| 06/22/2006 | US20060134604 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 06/22/2006 | US20060134130 Oral drug delivery compositions and methods |
| 06/22/2006 | CA2634589A1 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 06/22/2006 | CA2589042A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 06/21/2006 | EP1670814A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compounds |
| 06/21/2006 | EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/21/2006 | EP1670434A1 Methods for preparing oil bodies comprising active ingredients |
| 06/21/2006 | EP1587941A4 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 06/21/2006 | EP0914342B1 Polymeric somatostatin derivatives useful for promoting body growth |
| 06/21/2006 | CN1791599A 丙型肝炎抑制剂化合物 Hepatitis C inhibitor compounds |
| 06/21/2006 | CN1789278A Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 06/21/2006 | CN1789277A Diisopropoxy phosphoryl dipeptide trimethoxy benzamide compound and its preparation process |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064105 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/20/2006 | US7063948 antibodies recognizing acetylcholinesterase or a C-terminal peptide derived from acetyl-cholinesterase, useful in diagnosing central nervous system stress |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062424A2 Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system |
| 06/15/2006 | WO2006061714A2 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 06/15/2006 | WO2006022664A3 Alanine 2, 3 aminomutases |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128754 tubulysin derivatives used as antitumor agents |
| 06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
| 06/15/2006 | US20060128632 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128614 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/14/2006 | EP1669463A1 Casein hydrolyzate, process for producing the same and use thereof |
| 06/14/2006 | EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1372693B1 Peptides for the treatment of wound contracture |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1787831A Methods for preventing mitochondrial permeability transition |
| 06/14/2006 | CN1786019A Manufacturing method of proglu-dipeptide |
| 06/13/2006 | US7060842 Catalytic hydrogenation; crystallization; isolation |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060678 peptidomimetic analogs of VIP receptor binding inhibitors replacing the di-/tri-peptides having proline as one of the amino acids, or proline alone, with at leat one unit from enantiomorphic 4-(aminomethyl)tetrahydrofuran-2-carboxylic acid |
| 06/13/2006 | US7060266 Human brain carboxypeptidase B |
| 06/13/2006 | US7060248 Chelate compounds; diagnosis of disease; detection of conjestive heart failurel |
| 06/08/2006 | WO2006059164A2 Pyrrolopyridine-2-carboxylic acid amides |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122267 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 06/08/2006 | US20060122184 Cyanomethyl derivatives as cysteine protease inhibitors |
| 06/08/2006 | US20060122125 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 06/08/2006 | US20060122123 Hepatitis C; 1-benzyloxycarbonylamino-2-vinyl-cyclopropyl)-phenyl-phosphinic acid ethyl ester |
| 06/08/2006 | US20060122101 Drug for preventing, regulating or treating adhesion |
| 06/08/2006 | US20060122100 Melanin extinguisher |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |